Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis
about
Integrating Antiretroviral Strategies for Human Immunodeficiency Virus Prevention: Post- and Pre-Exposure Prophylaxis and Early TreatmentPreventing HIV infection: pre-exposure and postexposure prophylaxisChoice of antiretroviral drugs for postexposure prophylaxis for adults and adolescents: a systematic reviewPractical guidance for nonoccupational postexposure prophylaxis to prevent HIV infection: an editorial reviewAntiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061Risks associated with lentiviral vector exposures and prevention strategiesNeedlestick and Sharps Injuries in Dermatologic Surgery: A Review of Preventative Techniques and Post-exposure ProtocolsAntiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxisAntiretroviral Drug Use in a Cohort of HIV-Uninfected Women in the United States: HIV Prevention Trials Network 064Drug safety evaluation of oral tenofovir disoproxil fumarate-emtricitabine for pre-exposure prophylaxis for human immunodeficiency virus infection.Pharmacokinetics of antiretrovirals in genital secretions and anatomic sites of HIV transmission: implications for HIV prevention.Uptake and repeat use of postexposure prophylaxis in a community-based clinic in Los Angeles, California.Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here?Sexually transmitted diseases treatment guidelines, 2015.Prevention of human immunodeficiency virus and AIDS: postexposure prophylaxis (including health care workers)Update on the Epidemiology and Prevention of HIV/AIDS in the United States.Human T-cell lymphotropic virus type 1 exposures following blood-borne virus incidents in central Australia, 2002-2012.Postexposure prophylactic effect of hepatitis B virus (HBV)-active antiretroviral therapy against HBV infection.Contingency management facilitates the use of postexposure prophylaxis among stimulant-using men who have sex with menPharmacokinetic profile of raltegravir, elvitegravir and dolutegravir in plasma and mucosal secretions in rhesus macaquesOverexpression of mitochondrial antioxidant manganese superoxide dismutase (MnSOD) provides protection against AZT- or 3TC-induced endothelial dysfunction.Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigmThe Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV PreventionAwareness and low uptake of post exposure prophylaxis for HIV among clinical medical students in a high endemicity setting.Prescription of Non-Occupational Post-Exposure HIV Prophylaxis by Emergency Physicians: An Analysis on Accuracy of Prescription and Compliance.Post exposure prophylaxis following occupational exposure to HIV: a survey of health care workers in Mbeya, Tanzania, 2009-2010.Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis.Occupational exposure to blood borne pathogens among healthcare workers: a cross-sectional study of a registry in ColombiaSharps injuries among emergency department nurses in one tertiary care hospital in GhanaAddressing the increasing burden of sexually transmitted infections in Rhode Island.Epidemiology and clinical consequences of occupational exposure to blood and other body fluids in a university hospital in Saudi ArabiaInfection control best practices in clinical research in resource-limited settings.The importance of implementing safe sharps practices in the laboratory setting in Europe.Overviewing a Nurse-Led, Community-Based HIV PEP Program: Applying the Extant Literature in Frontline Practice.Compliance with infection prevention and control in oral health-care facilities: a global perspective.Choice of antiretroviral drugs for postexposure prophylaxis for children: a systematic review.Postexposure prophylaxis after hepatitis C occupational exposure in the interferon-free eraAcute Care Management of the HIV-Infected Patient: A Report from the HIV Practice and Research Network of the American College of Clinical Pharmacy.Formulating the Future Research Agenda for Postexposure Prophylaxis for HIV: Methodological Challenges and Potential Approaches.Acute coronary syndromes in patients with HIV.
P2860
Q26778085-A3242D1D-88CD-45CF-A57E-225F06E48A39Q26828445-5909BA36-8AE8-4017-A270-EDF99744C7DEQ26851448-F2D6FD9A-8EF5-4D0D-82F9-1418BB8D227AQ26853055-40855824-AD12-455D-AACE-A9F5E4495600Q27312940-70043CF9-EB6B-4D95-811D-80D29BCFC0D6Q28065064-BA041EF5-3CA1-4FBE-82E5-65121392D97DQ28080029-74BFD430-2355-4569-9E10-4D732ABB8548Q28085433-53718B13-7493-4490-ADF6-81B4E3E93F58Q28550081-7787F335-2CC6-437A-9FB9-99831C875287Q30249113-DADE5580-08A2-4D4B-B277-3C59A2FB5569Q33888718-1C459AEF-F0DC-4F66-B096-7BCD099B4AA1Q34116802-3FD89A35-FD65-481F-B5CA-74F0F2A088E9Q34379806-869ED38F-8A76-44EB-982C-A57C06457C9FQ34479272-D52B2B8E-87D2-4A19-9429-9E20BB99240FQ34619859-2A65149A-BAB7-4794-BFF6-956FD68492C5Q34669756-7BE3CB43-1C54-4C49-8AE0-D74E6BBBE5C8Q35008382-985718F4-386D-4D3C-9E0F-0E63EE896F6CQ35105851-DE9B05A7-0218-4C1C-B9BD-7939C324CD71Q35408032-FEE878DF-0B69-4B8E-AB7B-502ADF64F95AQ35432739-B619382E-3DA8-40EF-9F5F-717F4BBE8798Q35556516-0C2EF6B5-2FC9-4662-97ED-9CD5D11BD64FQ35780443-01246ABA-0528-4176-89F1-5A3A21AC7CCCQ35821208-525102F4-FC01-470B-8F2A-56EF85A7955DQ35834660-D50273C7-8AD7-4EDC-82D6-58CCFBABEC8BQ35987089-1956C996-1680-4CE3-9489-5F7038938218Q36042836-92E4BA3C-547B-4718-A38E-8344B28E0382Q36205915-C2FA7EB2-BE4B-4683-857A-5A0255C2415CQ36376722-D5E430A5-C61A-439C-B59F-FF00FB3299F0Q36887751-4B9B3EB8-C6FF-482E-9149-FB89FC6B1AA0Q37155917-280BEF23-3275-469C-9BB4-36FF100CBFFFQ37247225-3F5036CF-DA9D-4374-9432-4327D4BC4DFEQ37595390-79AB1B48-F89B-446E-971A-CC9943E6546CQ37607310-4A334BB0-EBA0-481B-A950-370FC51F7C3DQ38201865-1965CF64-BFB0-45EC-A3D1-C6CEA5E7B20CQ38253129-0EDA256F-2B0F-45C4-86F4-AE65F868D722Q38478669-679CD01F-6E04-42FA-B3D6-92A0D6F560E5Q38866134-01C6BA56-1E84-4D12-9FF2-A412ADE93918Q38920747-7BBEAE27-AF4F-4698-8CA2-6A2D4EF09629Q39007024-F69F4E2B-1F21-4031-A277-7708102D3DD8Q39009201-2DCE853D-7495-4B56-80ED-52FD96B3256D
P2860
Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Updated US Public Health Servi ...... s for Postexposure Prophylaxis
@nl
Updated US Public Health Servi ...... s for postexposure prophylaxis
@ast
Updated US Public Health Servi ...... s for postexposure prophylaxis
@en
type
label
Updated US Public Health Servi ...... s for Postexposure Prophylaxis
@nl
Updated US Public Health Servi ...... s for postexposure prophylaxis
@ast
Updated US Public Health Servi ...... s for postexposure prophylaxis
@en
prefLabel
Updated US Public Health Servi ...... s for Postexposure Prophylaxis
@nl
Updated US Public Health Servi ...... s for postexposure prophylaxis
@ast
Updated US Public Health Servi ...... s for postexposure prophylaxis
@en
P2093
P2860
P921
P3181
P356
P1476
Updated US Public Health Servi ...... s for postexposure prophylaxis
@en
P2093
Adelisa L. Panlilio
Ahmed Gomaa
David K. Henderson
David T. Kuhar
Kimberly A. Struble
Laura W. Cheever
Vasavi Thomas
P2860
P2880
P304
P3181
P356
10.1086/672271
P407
P577
2013-09-01T00:00:00Z